Global Intrauterine Contraceptive Market Forecast 2017-2025
KEY FINDINGS The intrauterine contraceptive device is a T-shaped birth control device which is placed inside a woman's uterus to prevent pregnancy. The Global Intrauterine Contraceptive market is projected to expand at a CAGR of 3.75%, increasing its revenue from $ 3534 million in 2016 to $4886 million by 2025 over the forecast period of 2017-2025. The key factors favoring the use of IUD devices include the fact that these devices are safer and effective as compared to other methods and can be used on a long-term basis. Also, the various government initiatives to curb the number of unsolicited pregnancies or abortions amongst the populace is hugely aiding the market expansion.
MARKET INSIGHTS The global intrauterine contraceptive device market is segmented on the basis of products and types. The segment for market by products include Skyla, Mirena, Paragard and other products whereas the market by type includes Copper ICD and Hormonal ICD. Presently, the copper ICD holds the biggest market share.
REGIONAL INSIGHTS The global intrauterine contraceptive device market covers regions like North America, Asia-Pacific, Europe and Rest of the World. The Asia-Pacific region is expected to hold the largest share over the course of the forecast period. The country of China is predicted to be the major contributor to this market owing to the stringent government directives and rising awareness regarding the use of IUC devices.
CONTRACEPTIVE INSIGHTS Pregna International Ltd is a reputed medical device company which deals with products like intrauterine devices (IUDs), intra-uterine enablers, and tubal rings. The company’s product range includes various forms of IUDs, ex: spiral, copper coil, copper IUD, and loop. Another major company in the market is the Allergan Plc, which develops, markets and distributes generic, branded generic, medical aesthetics and over-the-counter (OTC) pharmaceutical products all over the world. Some of the other established companies in the market include Bayers Ag, DKT International, Egemen International, HLL Lifecare Limited, Krishco Medical Products Pvt.Ltd, Medisafe Distribution Inc, Meril Life Sciences Private Limited, Merck & Co, Melbea, Mona Lisa N.V, Ocon Medical Ltd, Okamoto Industries Inc, Pfizer, SMB Corporation, Teva Pharmaceutical Industries Limited, Trimedic Supply Network Ltd and Zhejiang Daji Medical Instruments Co Ltd.